Achillion Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. ACHN has around 12.8M shares in the U.S. ETF market. The largest ETF holder of ACHN is the iShares Russell 2000 ETF (IWM), with approximately 3.17M shares. Investors may also find of interest that the ETF with the largest allocation to ACHN stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 1.75%. On average, U.S. ETFs allocate 0.12% of ACHN to their portfolios.
Additionally, ACHN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ACHN as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 35.89%.